There appears to be marked improvement in overall survival in people with multiple myeloma, according to a study involving 264 individuals.

Participants all had multiple myeloma with an initial visit occurring between 2004 and 2014. They had treatment at a clinic that specialized in the disorder. Investigators looked at progression-free, overall, and 5-year overall survival. Among the results:

  • Progression-free survival for frontline treatments was ~14 months; for salvage and all treatments it was 4.6 and 5.5 months, respectively.
  • Median overall survival in all patients was 98¬†months.
  • 5-year survival rate was 74%.

The authors noted that these findings should help physicians predict outcomes.